USPTO serial 75348556
MOLECULAR PHARMING
Reviewed by CopyMark Law Group
Reg. 2809625Status 710
- Filing date
- Status date
- Registration date
- Feb 3, 2004
- Examiner
- JACKSON, WILLIAM D
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with MOLECULAR PHARMING?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
F-6300 CLERMONT-FERRAND, FR
F-63000 CLERMONT-FERRAND, FR
63170 Aubiere, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
JENNIFER L. DEAN
JENNIFER L DEAN DRINKER BIDDLE & REATH LLP1500 K ST NW STE 1100WASHINGTON, DC 20005-1209UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemicals for use in the manufacture of diagnostic reagents, biomaterials for use in the biotechnological industry, for scientific use, for use in photography, and for agricultural use, namely, hormones, peptides, enzymes, proteins, growth hormones, growth regulators and inhibitors, cell growth media, cell regulatory agents, amino acids, DNA fragments, RNA fragments, DNA probes, RNA probes, genetic cloning materials, genetic expression amplifiers; biomaterials for use in the manufacture of genetically modified organisms; and chemicals extracted or expressed by genetically modified organisms for use in the manufacture of therapeutics and cosmetics | SECTION 8 - CANCELLED | — |
| 005 | pharmaceutical preparations for the treatment of diseases linked to genetic dysfunction, protein deficiency; veterinary preparations for the treatment of feline immunodeficiency virus, rabies, lipid update insufficiency, obesity, in pets and wild animals; sanitary preparations for domestic and hospital use, namely, bactericides, anti-bacterial hand washes, antiseptics, germicides, and sanitizers; all-purpose disinfectants for medical instruments, premises and patients; dietetic substances for medical use, namely, food for medically restricted diets, diabetics, intravenous nutrition, babies | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MERISTEM THERAPEUTICS
- Other trademarks owned by MERISTEM THERAPEUTICS
- Other trademarks owned by BIOCEM S.A.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named MOLECULAR PHARMING
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 10, 2010 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jun 7, 2007 | CFIT | CASE FILE IN TICRS | — |
| Apr 23, 2004 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Feb 20, 2004 | AMD7 | SEC 7 REQUEST FILED | — |
| Feb 3, 2004 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 25, 2003 | REIN | REINSTATED | — |
| May 22, 2003 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 20, 2003 | 1.BD | Sec. 1(B) CLAIM DELETED | — |
| Feb 20, 2003 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Feb 20, 2003 | PAPER RECEIVED | — | |
| Oct 16, 2002 | PAPER RECEIVED | — | |
| Aug 20, 2002 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 8, 1999 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Sep 7, 1999 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 6, 1999 | NPUB | NOTICE OF PUBLICATION | — |
| May 11, 1999 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 7, 1999 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Apr 22, 1999 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 5, 1999 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 6, 1998 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 30, 1998 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 7, 1998 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 27, 1998 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 7, 1998 | DOCK | ASSIGNED TO EXAMINER | — |